Inventor
DIANNE SAKO
Inventor
US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07KPeptides31%
C12NMicroorganisms or enzymes6%
C12YEnzymes3%
PatentTitleYear
12,545,736ActRII-binding proteins and uses thereof202612,365,736ALK7 binding proteins and uses thereof202512,338,273Single-arm type I and type II receptor fusion proteins and uses thereof202512,258,380ALK4:actriib heteromultimers and uses thereof202512,145,970Twisted gastrulation polypeptides and uses thereof202412,042,524Activin type 2 receptor binding proteins methods of making them202411,981,738ALK7 binding proteins and uses thereof202411,827,689ALK7:ActRIIB heteromultimers and uses thereof202311,708,414ALK7 binding proteins and uses thereof202311,279,746ALK4:ActRIIB heteromultimers and uses thereof202211,208,460Single-arm type I and type II receptor fusion proteins and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to ACCELERON PHARMA INC (10)· patent assignee history
2021–2026Based in US· patent location history
2024Patents assigned to ADIMAB LLC (1)· patent assignee history
2025Patents assigned to ACCERELON PHARMA INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ACCELERON PHARMA INC | 10 | 2021–2026 |
| ACCERELON PHARMA INC | 1 | 2025 |
| ADIMAB LLC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 11 | 2021–2026 |